Regeneron Files Q1 2025 10-Q
Ticker: REGN · Form: 10-Q · Filed: Apr 29, 2025 · CIK: 872589
| Field | Detail |
|---|---|
| Company | Regeneron Pharmaceuticals, Inc. (REGN) |
| Form Type | 10-Q |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Regeneron's Q1 2025 10-Q is in. Financials look solid.
AI Summary
Regeneron Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the first quarter of 2025. Key financial figures and business segment performances are presented, reflecting the company's ongoing activities in the pharmaceutical sector.
Why It Matters
This filing provides investors and analysts with the latest financial health and operational details of Regeneron Pharmaceuticals, Inc., crucial for understanding the company's current performance and future outlook.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Numbers
- 20250331 — Period End Date (The filing covers financial data up to this date.)
- 2024-12-31 — Previous Period End Date (Comparison point for financial data.)
Key Players & Entities
- REGENERON PHARMACEUTICALS, INC. (company) — Filer
- 0000872589 (company) — Central Index Key
- TARRYTOWN, NY (location) — Business Address
- 20250331 (date) — Period of Report
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the filing covers the first quarter of 2025.
What is Regeneron Pharmaceuticals, Inc.'s Central Index Key (CIK)?
Regeneron Pharmaceuticals, Inc.'s Central Index Key is 0000872589.
Where is Regeneron Pharmaceuticals, Inc. headquartered?
The company's business address is 777 Old Saw Mill River Road, Tarrytown, NY 10591.
What is the Standard Industrial Classification (SIC) code for Regeneron Pharmaceuticals, Inc.?
The SIC code is 2834, which corresponds to Pharmaceutical Preparations.
When was this 10-Q filing submitted?
This filing was submitted on 20250429.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 29, 2025 regarding REGENERON PHARMACEUTICALS, INC. (REGN).